GlaxoSmithKline Consumer Nigeria Plc reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was NGN 7,360.03 million compared to NGN 3,461.89 million a year ago. Net income was NGN 194.37 million compared to net loss of NGN 238.07 million a year ago. Basic earnings per share from continuing operations was NGN 0.16 compared to basic loss per share from continuing operations of NGN 0.2 a year ago. Diluted earnings per share from continuing operations was NGN 0.16 compared to diluted loss per share from continuing operations of NGN 0.2 a year ago.